Columbia Labs granted Plethora exclusive rights to market Striant SR for testosterone replacement therapy in the U.K.

Columbia Laboratories Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Plethora Solutions Holdings plc

U.K. / Medical Devices and Diagnostics

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced